- Home
- CMCL vs BWAY Comparison
CMCL vs BWAY Comparison
Compare CMCL & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCL
- BWAY
- Stock Information
- Founded
- CMCL 1992
- BWAY 2003
- Country
- CMCL Jersey
- BWAY Israel
- Employees
- CMCL N/A
- BWAY N/A
- Industry
- CMCL Precious Metals
- BWAY Medical/Dental Instruments
- Sector
- CMCL Basic Materials
- BWAY Health Care
- Exchange
- CMCL Nasdaq
- BWAY Nasdaq
- Market Cap
- CMCL 181.6M
- BWAY 177.4M
- IPO Year
- CMCL N/A
- BWAY 2019
- Fundamental
- Price
- CMCL $9.33
- BWAY $9.74
- Analyst Decision
- CMCL Buy
- BWAY Strong Buy
- Analyst Count
- CMCL 1
- BWAY 3
- Target Price
- CMCL $13.50
- BWAY $13.17
- AVG Volume (30 Days)
- CMCL 71.4K
- BWAY 46.2K
- Earning Date
- CMCL 11-11-2024
- BWAY 11-12-2024
- Dividend Yield
- CMCL 4.49%
- BWAY N/A
- EPS Growth
- CMCL N/A
- BWAY N/A
- EPS
- CMCL 0.48
- BWAY 0.04
- Revenue
- CMCL $165,346,000.00
- BWAY $38,631,000.00
- Revenue This Year
- CMCL $31.50
- BWAY $378.91
- Revenue Next Year
- CMCL $9.45
- BWAY $20.27
- P/E Ratio
- CMCL $19.35
- BWAY $120.99
- Revenue Growth
- CMCL 22.97
- BWAY 34.19
- 52 Week Low
- CMCL $8.91
- BWAY $4.61
- 52 Week High
- CMCL $16.95
- BWAY $10.98
- Technical
- Relative Strength Index (RSI)
- CMCL 33.99
- BWAY 54.25
- Support Level
- CMCL $9.12
- BWAY $8.90
- Resistance Level
- CMCL $9.93
- BWAY $9.49
- Average True Range (ATR)
- CMCL 0.45
- BWAY 0.34
- MACD
- CMCL 0.10
- BWAY 0.04
- Stochastic Oscillator
- CMCL 12.59
- BWAY 100.00
About CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.